0001437749-22-009745 | 20-F | XBRL Viewer

Note 8 - Income Tax - Summary of Income Tax (Expense) Benefit (Details) - USD ($)
$ in Thousands

12 Months Ended

Dec. 31, 2021

Dec. 31, 2020

Dec. 31, 2019

Currency effect on income tax (expense) benefit and adjustments recognized in the period for current tax of prior periods (1)

^[1]

$ 852

$ (1,272)

$ (322)

Income tax benefit (expense)

$ 194

$ 1,876

$ (5,602)

[1]	Currency effect on income tax (expense) benefit due to corporate income tax filing in NOK for Norwegian entities with USD as functional currency.

Note 10 - Property and Equipment (Tables)

12 Months Ended

Dec. 31, 2021

Statement Line Items [Line Items]

Disclosure of detailed information about the estimated useful lives of property, plant and equipment [text block]

	Office properties	Fixture and fittings	Equipment	Leasehold improvements
Useful life	Up to 6 years	Up to 5 years	Up to 10 years, or term of lease contract	Up to 6 years, or term of lease contract
Depreciation method	Straight-line	Straight-line	Straight-line	Straight-line

Note 5 - Personnel Expenses, Including Share-based Remuneration (Tables)

12 Months Ended

Dec. 31, 2021

Statement Line Items [Line Items]

Disclosure of personnel expenses including share-based remuneration [text block]

	Year ended December 31,
[US$ thousands]	2019		2020		2021
Salaries, including bonuses		42,185		40,301		43,440
Social security tax, excluding amounts related to share-based remuneration		3,774		4,624		5,371
External temporary hires		2,474		7,090		8,617
Defined contribution pension expense		3,616		3,279		4,477
Other personnel-related expenses		4,345		2,103		2,080
Total personnel expenses, excluding share-based remuneration		56,395		57,397		63,984
Share-based remuneration, including related social security tax		5,928		4,706		10,466
Total personnel expenses, including share-based remuneration		62,323		62,103		74,450

Disclosure of number and weighted average exercise prices of share options and other equity instruments [text block]

	RSUs			Options			Total
Outstanding as of January 1, 2020		2,983,940			150,000			3,133,940
Granted during the year		401,818			-			401,818
Forfeited during the year		(346,200	)		-			(346,200	)
Exercised during the year		(1,122,818	)		-			(1,122,818	)
Expired during the year		-			-			-
Outstanding as of December 31, 2020		1,916,740			150,000			2,066,740
Granted during the year		1,990,825			40,000			2,030,825
Forfeited during the year		(154,700	)		(90,000	)		(244,700	)
Exercised during the year		(1,086,340	)		-			(1,086,340	)
Expired during the year		-			-			-
Outstanding as of December 31, 2021		2,666,525			100,000			2,766,525

Disclosure of indirect measurement of fair value of goods or services received, other equity instrument granted during period [text block]

	2020 grants: RSU valuation input			2021 grants: RSU valuation input			2021 grants: Option valuation input
Equity unit price valuation ($)		8.07			10.49			10.48
Model Used		Monte Carlo			Monte Carlo			Black-Scholes
Expected Volatility (%) ^{(1), (2)}		40.00	%		66.55	%		68.10	%
Risk free interest rate (%) ⁽¹⁾		0.58	%		0.22	%		0.46	%
Dividend Yield (%)		0	%		0	%		0	%
Duration of initial simulation period (years to longstop date)		3.81			3.23			3.02
Duration of second simulation period with postponed exercise (years)		3.00			3.00			3.00
Fair value at the measurement date ($)		7.84			10.35			4.96

Note 5 - Personnel Expenses, Including Share-based Remuneration - Personnel Expenses (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Statement Line Items [Line Items]
External temporary hires	$ 8,617	$ 7,090	$ 2,474
Total personnel expenses, excluding share-based remuneration	63,984	57,397	56,395
Share-based remuneration, including related social security tax	$ 10,466	$ 4,706	$ 5,928

Note 9 - Net Income Per Share - Income (Loss) Per Share (Details) - shares	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Statement Line Items [Line Items]
Effect of shares bought to treasury (in shares)	(164,324)	(5,146,244)	(2,913,330)

Note 7 - Finance Income and Expense (Tables)

12 Months Ended

Dec. 31, 2021

Statement Line Items [Line Items]

Disclosure of detailed information about finance income (cost) [text block]

	Year ended December 31,
[US$ thousands]	2019			2020			2021
Finance income:
Interest income		2,045			326			35
Net gain on investment portfolio held for trading (Note 14)		8,477			13,033			-
Other finance income		10			275			88
Total finance income		10,532			13,633			123
Finance expense:
Interest expense		(562	)		(447	)		(316	)
Net loss on investment portfolio held for trading (Note 14)		-			-			(4,944	)
Other finance costs		(93	)		(69	)		(1,652	)
Total finance expense		(655	)		(516	)		(6,912	)
Foreign exchange gain (loss):
Unrealized foreign exchange gain (loss)		166			2,365			(494	)
Realized foreign exchange gain (loss)		(191	)		(1,532	)		(1,320	)
Total foreign exchange gain (loss)		(25	)		833			(1,814	)
Net finance income (expense)		9,851			13,950			(8,603	)

Note 17 - Financial Risk Management (Details Textual) $ in Millions	Dec. 31, 2021 USD ($)
Statement Line Items [Line Items]
Maximum capital allocation to investments	$ 70
Investment, interest rate	8.00%

Label	Element	Value
opra_CashFlowsUsedInDepositOfCollateralForLoanFacility	opra_CashFlowsUsedInDepositOfCollateralForLoanFacility	$ 52,878,000
opra_CashFlowsUsedInDepositOfCollateralForLoanFacility	opra_CashFlowsUsedInDepositOfCollateralForLoanFacility	1,000,000
opra_CashFlowsUsedInDepositOfCollateralForLoanFacility	opra_CashFlowsUsedInDepositOfCollateralForLoanFacility	(0)
opra_NetProceedsFromPurchaseAndSaleOfListedEquityInstruments	opra_NetProceedsFromPurchaseAndSaleOfListedEquityInstruments	35,250,000
opra_NetProceedsFromPurchaseAndSaleOfListedEquityInstruments	opra_NetProceedsFromPurchaseAndSaleOfListedEquityInstruments	(58,535,000)
opra_NetProceedsFromPurchaseAndSaleOfListedEquityInstruments	opra_NetProceedsFromPurchaseAndSaleOfListedEquityInstruments	84,835,000
opra_FinanceIncomeCostIncludingDiscontinuedOperations	opra_FinanceIncomeCostIncludingDiscontinuedOperations	8,756,000
opra_FinanceIncomeCostIncludingDiscontinuedOperations	opra_FinanceIncomeCostIncludingDiscontinuedOperations	11,980,000
opra_FinanceIncomeCostIncludingDiscontinuedOperations	opra_FinanceIncomeCostIncludingDiscontinuedOperations	(8,603,000)
opra_ImpactOfNewAccountingPrincipleInPeriodOfAdoption	opra_ImpactOfNewAccountingPrincipleInPeriodOfAdoption	0
opra_ImpactOfNewAccountingPrincipleInPeriodOfAdoption	opra_ImpactOfNewAccountingPrincipleInPeriodOfAdoption	0
opra_ImpactOfNewAccountingPrincipleInPeriodOfAdoption	opra_ImpactOfNewAccountingPrincipleInPeriodOfAdoption	64,000
opra_ImpactOfNewAccountingPrincipleInPeriodOfAdoption	opra_ImpactOfNewAccountingPrincipleInPeriodOfAdoption	0
opra_ImpactOfNewAccountingPrincipleInPeriodOfAdoption	opra_ImpactOfNewAccountingPrincipleInPeriodOfAdoption	64,000
Current lease liabilities and other loans	opra_CurrentLeaseLiabilitiesAndOtherLoans	5,389,000
Current lease liabilities and other loans	opra_CurrentLeaseLiabilitiesAndOtherLoans	11,427,000
Release of escrow account	opra_ProceedsFromReleaseOfEscrowAccount	0
Release of escrow account	opra_ProceedsFromReleaseOfEscrowAccount	1,000,000
Release of escrow account	opra_ProceedsFromReleaseOfEscrowAccount	0
opra_DisbursementOfShorttermLoans	opra_DisbursementOfShorttermLoans	(0)
opra_DisbursementOfShorttermLoans	opra_DisbursementOfShorttermLoans	6,332,000
opra_DisbursementOfShorttermLoans	opra_DisbursementOfShorttermLoans	(0)
opra_EquityAdjustedBalance	opra_EquityAdjustedBalance	22,000
opra_EquityAdjustedBalance	opra_EquityAdjustedBalance	738,690,000
opra_EquityAdjustedBalance	opra_EquityAdjustedBalance	36,496,000
opra_EquityAdjustedBalance	opra_EquityAdjustedBalance	316,000
opra_EquityAdjustedBalance	opra_EquityAdjustedBalance	775,524,000
Impairment of equity-accounted investee	opra_AdjustmentsForImpairmentLossRecognisedInProfitOrLossAssociatesAndJointVentures	0
Impairment of equity-accounted investee	opra_AdjustmentsForImpairmentLossRecognisedInProfitOrLossAssociatesAndJointVentures	0
Impairment of equity-accounted investee	opra_AdjustmentsForImpairmentLossRecognisedInProfitOrLossAssociatesAndJointVentures	118,178,000
Impact of divestment of joint venture	opra_AdjustmentsForImpactOfDivestitureOfJointVenture	0
Impact of divestment of joint venture	opra_AdjustmentsForImpactOfDivestitureOfJointVenture	1,834,000
Impact of divestment of joint venture	opra_AdjustmentsForImpactOfDivestitureOfJointVenture	0
Repayment of short-term loans	opra_RepaymentOfShorttermLoan	0
Repayment of short-term loans	opra_RepaymentOfShorttermLoan	6,332,000
Repayment of short-term loans	opra_RepaymentOfShorttermLoan	0
opra_MarketingAndDistributionExpense	opra_MarketingAndDistributionExpense	65,074,000
opra_MarketingAndDistributionExpense	opra_MarketingAndDistributionExpense	47,860,000
opra_MarketingAndDistributionExpense	opra_MarketingAndDistributionExpense	120,944,000
opra_TotalCashAndCashEquivalentsAndMarketableSecurities	opra_TotalCashAndCashEquivalentsAndMarketableSecurities	134,168,000
opra_TotalCashAndCashEquivalentsAndMarketableSecurities	opra_TotalCashAndCashEquivalentsAndMarketableSecurities	181,011,000
Non-current lease liabilities and other loans	opra_NoncurrentLeaseLiabilitiesAndOtherLoans	3,584,000
Non-current lease liabilities and other loans	opra_NoncurrentLeaseLiabilitiesAndOtherLoans	$ 2,081,000

Note 9 - Net Income Per Share (Details Textual)	12 Months Ended
Note 9 - Net Income Per Share (Details Textual)	Dec. 31, 2021 shares
Statement Line Items [Line Items]
Number of instruments with potential future dilutive effect not included in calculation of diluted earnings per share (in shares)	2,766,525
Number of ordinary shares per share of ADS (in shares)	2

Note 15 - Lease Liabilities and Other Loans - Lease Amounts Included in Financial Statements (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Statement Line Items [Line Items]
Foreign exchange loss	$ (277)	$ (140)
Total lease-related expenses	$ 7,400	$ 8,489

Note 19 - Events After the Reporting Period (Details Textual) $ in Thousands		12 Months Ended
	Mar. 22, 2022 USD ($)	Dec. 31, 2021 USD ($) shares	Apr. 21, 2022 USD ($)	Mar. 31, 2022 shares	Jan. 20, 2022 USD ($)	Jan. 17, 2021 shares	Dec. 31, 2020 USD ($)	Jan. 17, 2020 USD ($)	Dec. 31, 2019 shares
Statement Line Items [Line Items]
Share repurchase program, maximum authorized amount					$ 50,000			$ 50,000
Number of shares repurchased (in shares) \| shares		9,854,594		569,352		5,976,455			1,500,000
Disposal group held for sale, consideration to be received	$ 127,100	$ 127,100	$ 83,500
Disposal group held for sale, consideration to be received, number of quarterly installments	8	8
Disposal group held for sale, consideration to be received, term (Year)	2 years	2 years
Current assets or disposal groups classified as held for sale	$ 120,300	$ 288,379					$ 0
Disposal group held for sale, discount rate	5.00%	5.00%
Disposal group, installment due within 10 days			$ 28,400
Disposal group, number of installments			2
Disposal group, deferred payments, interest rate			3.50%

Note 15 - Lease Liabilities and Other Loans (Tables)

12 Months Ended

Dec. 31, 2021

Statement Line Items [Line Items]

Disclosure of borrowings and finance lease liabilities [text block]

	As of December 31,
[US$ thousands]	2020		2021
Non-current lease liabilities and other loans:
Lease liabilities		3,094		1,925
Interest-bearing loans		490		155
Total non-current lease liabilities and other loans		3,584		2,081
Current lease liabilities and other loans:
Lease liabilities		4,706		3,449
Interest-bearing loans		311		7,784
Other loans		371		194
Total current lease liabilities and other loans		5,389		11,427
Total lease liabilities and other loans		8,972		13,508

Disclosure of lease amounts included in financial statements [text block]

	As of December 31,
[US$ thousands]	2020		2021
Right-of-use assets:
Office properties (Note 10)		4,974		4,171
Equipment (Note 10)		2,335		1,070
Total right-of-use assets		7,309		5,241
Lease liabilities:
Non-current		3,094		1,925
Current		4,706		3,449
Total lease liabilities		7,800		5,374

	Year ended December 31,
[US$ thousands]	2020		2021
Depreciation expense of right-of-use assets classified as property		2,221		2,407
Depreciation expense of right-of-use assets classified as equipment		2,529		2,347
Interest expense (included in finance expense)		397		266
Expense relating to short-term leases (included in other operating expenses)		3,201		2,104
Foreign exchange loss		140		277
Total lease-related expenses		8,489		7,400

Note 6 - Other Operating Expenses

12 Months Ended

Dec. 31, 2021

Statement Line Items [Line Items]

Disclosure of other expenses [text block]

Note 6.

Other Operating Expenses

The table below specifies the nature of other operating expenses.

	Year ended December 31,
[US$ thousands]	2019		2020		2021
Hosting		7,344		8,056		7,647
Audit, legal and other advisory services ⁽¹⁾		6,742		10,863		6,579
Software license fees		2,397		1,882		1,782
Rent and other office expenses		4,175		3,318		3,152
Travel		3,903		1,304		542
Other		3,686		2,774		3,101
Total other operating expenses		28,248		28,197		22,802

(1)	Amount in 2020 includes US$3.5 million related to actions taken following a short seller report.

Note 4 - Segment and Revenue Information - Other Income (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Statement Line Items [Line Items]
Gain on divestment of joint venture	$ 0	$ 2,063	$ 0
Government granted VAT refund	0	4,030	0
Other items	$ 466	$ 160	$ 0

Note 5 - Personnel Expenses, Including Share-based Remuneration - Fair Value Measurement (Details)

12 Months Ended

Dec. 31, 2021

Dec. 31, 2020

Statement Line Items [Line Items]

Expected Volatility (%) (1), (2)

^[1],[2]

66.55%

40.00%

Risk free interest rate (%) (1)

^[2]

0.22%

0.58%

Dividend Yield (%)

0.00%

Duration of initial simulation period (years to longstop date) (Year)

3 years 2 months 23 days

3 years 9 months 21 days

Duration of initial simulation period (years to longstop date), option (Year)

3 years 7 days

Duration of second simulation period with postponed exercise (years) (Year)

3 years

Duration of second simulation period with postponed exercise (years), option (Year)

3 years

[1]	Based on a defined peer group of companies considered comparable to the Group.
[2]	Specified value is 4 years (modeled on yearly basis).

Significant Accounting Policies (Policies)	12 Months Ended
Significant Accounting Policies (Policies)	Dec. 31, 2021
Discloure of Significant Accounting Policies
Description of accounting policy for new standards, interpretations, and amendments [text block]	*New Standards, Interpretations, and Amendments* The accounting policies applied in the preparation of the consolidated financial statements are consistent with those applied in the preparation of the consolidated financial statements for the year ended December 31, 2020. Certain amendments to IFRS apply for the first time in 2021, but these did not have any impact on the consolidated financial statements. Except for the amendments to IFRS 10 and IAS 28 for sales or contributions of assets between an investor and its associate or joint venture, Opera has not early adopted standards, interpretations or amendments that have been issued but are not yet effective. None of the new and amended standards that are issued but not yet effective are expected to have a material impact on Opera’s consolidated financial statements when they are implemented in future periods.
Description of accounting policy for consolidation [text block]	*Basis of Consolidation* The consolidated financial statements comprise the financial statements of Opera Limited and entities it controls. Control is achieved when Opera is exposed, or has rights, to variable returns from its involvement with an investee and has the ability to affect those returns through its power over the investee. Generally, there is a presumption that a majority of voting rights results in control. If Opera loses control over a subsidiary, it derecognizes the related assets (including goodwill), liabilities, non-controlling interest, and other components of equity, while any resultant gain or loss is recognized in profit or loss. Any investment retained is recognized at fair value, including any retained interest in a former subsidiary comprising a business that is sold or contributed to an equity-accounted investee.
Description of accounting policy for other income [text block]	*Other Operating Income* Other operating income is income which is not related to Opera’s ordinary activities. Other operating income includes the gain on disposals of fixed and intangible assets, loss of control over subsidiaries and the gain on disposal of equity-accounted investees.
Description of accounting policy for personal expenses [text block]	*Personnel Expenses Including Share-based Remuneration* Personnel expenses, other than share-based payments to employees, include short-term employee benefits, such as wages, salaries, and social security contributions, paid annual leave and paid sick leave, performance-based bonuses, and non-monetary benefits. It also includes expenses related to defined contribution schemes provided to employees as post-employment benefits. These personnel expenses are recognized at the undiscounted amount due to the employees or the de-facto employees when these have rendered service to Opera or when the liability otherwise arises. Opera has established an employee equity plan to provide long-term incentives for its employees, whereby employees render services as consideration for equity instruments. The cost of equity-settled transactions is determined by the fair value at the date when the grant is made using an appropriate valuation model, further details of which are given in Note 5. That cost is recognized in the Statement of Operations, together with a corresponding increase in equity (retained earnings), over the period in which the service is provided (“the vesting period”). The cumulative expense recognized for equity-settled transactions at each reporting date until the vesting date reflects the extent to which the vesting period has expired and Opera’s best estimate of the number of equity instruments that will ultimately vest. The expense or credit in the Statement of Operations for a period represents the movement in cumulative expense recognized as at the beginning and end of that period.
Description of accounting policy for assets or disposal groups classified as held for sale [text block]	*Assets Held for Sale* Opera classifies non-current assets as held for sale if it is highly probable that they will be recovered primarily through sale rather than through continuing use. For a sale to be highly probable, actions required to complete the sale should indicate that it is unlikely that significant changes to the sale will be made or that the decision to sell will be withdrawn. Management must be committed to the plan to sell the asset and the sale expected to be completed within one year from the date of the classification. Moreover, the asset must be available for immediate sale in its present condition. Non-current assets held for sale are measured at the lower of their carrying amount and fair value less costs to sell, except for financial assets held for sale, which continue to be measured in accordance with the accounting policies for such assets, as outlined above. Once classified as held for sale, investments in associates and joint ventures are no longer accounted for in accordance with the equity method. Assets classified as held for sale are presented separately as current items in the Statement of Financial Position.

Note 17 - Financial Risk Management - Financial Liabilities (Details) - USD ($) $ in Thousands	Dec. 31, 2021	Dec. 31, 2020
Statement Line Items [Line Items]
Non-current financial liabilities, including interest	$ 160	$ 505
Current financial liabilities, including interest	7,793	337
Total financial liabilities, including interest	$ 71,280	$ 47,541

Note 3 - Corporate Information and Group Composition (Tables)

12 Months Ended

Dec. 31, 2021

Statement Line Items [Line Items]

Disclosure of gain (loss) on loss of control of discontinued operation [text block]

	As of August 19,
[US$ thousands]	2020
Fair value of shares in Nanobank		264,936
Less: Carrying amount of net assets disposed of		22,766
Less: Carrying amount of TenSpot Pesa Limited receivables transferred to Nanobank		87,867
Gain on sale before income tax and reclassification of foreign currency translation reserve		154,304
Reclassification of foreign currency translation reserve		(2,936	)
Income tax expense on gain		-
Gain on sale after income tax		151,368

Note 3 - Corporate Information and Group Composition - Gain on Loss of Control (Details) $ in Thousands	Aug. 19, 2020 USD ($)
Statement Line Items [Line Items]
Fair value of shares in Nanobank	$ 264,936
Less: Carrying amount of net assets disposed of	22,766
Less: Carrying amount of TenSpot Pesa Limited receivables transferred to Nanobank	87,867
Gain on sale before income tax and reclassification of foreign currency translation reserve	$ 154,304

Note 16 - Trade and Other Payables, and Other Current Liabilities - Trade and Other Payables, and Other Current Liabilities (Details) - USD ($)
$ in Thousands

Dec. 31, 2021

Dec. 31, 2020

Statement Line Items [Line Items]

Trade payables due to third party suppliers

$ 32,506

$ 20,181

Employee withholding tax

1,737

1,044

Payroll tax

^[1]

982

799

Accrued personnel expenses

11,793

11,985

Other current liabilities

$ 401

$ 310

[1]	Includes accruals for social security costs related to share-based remuneration.

Note 13 - Trade Receivables, Other Current Receivables, and Prepayments - Aging of Trade Receivables (Details) - USD ($) $ in Thousands	Dec. 31, 2021	Dec. 31, 2020
Statement Line Items [Line Items]
Weighted-average expected credit loss rate	6.00%	21.00%
Gross carrying amount	$ 5,036	$ 9,074
Loss allowance as of December 31	$ 2,533	$ 7,477

Note 11 - Goodwill and Intangible Assets (Tables)

12 Months Ended

Dec. 31, 2021

Statement Line Items [Line Items]

Disclosure of intangible assets with indefinite and definite useful life [text block]

		Customer			Other intangible
	Goodwill	relationships	Technology	Trademarks	assets
Useful life	Indefinite	Up to 15 years	Up to 5 years	Indefinite	Up to 5 years
Amortization method		Straight-line	Straight-line		Straight-line

Note 2 - Accounting Judgments and Estimation Uncertainty (Details Textual) $ in Thousands		12 Months Ended
	Mar. 22, 2022 USD ($)	Dec. 31, 2021 USD ($)	Apr. 21, 2022 USD ($)	Dec. 31, 2020 USD ($)
Statement Line Items [Line Items]
Disposal group held for sale, consideration to be received	$ 127,100	$ 127,100	$ 83,500
Disposal group held for sale, consideration to be received, number of quarterly installments	8	8
Disposal group held for sale, consideration to be received, term (Year)	2 years	2 years
Disposal group held for sale, discount rate	5.00%	5.00%
Current assets or disposal groups classified as held for sale	$ 120,300	$ 288,379		$ 0
Financial assets at fair value through profit or loss, redemption right		8.00%
Financial assets at fair value through profit or loss, liquidation preference		100.00%
Financial assets at fair value through profit or loss, dividend right		8.00%

Note 15 - Lease Liabilities and Other Loans (Details Textual)	12 Months Ended
	Dec. 31, 2021
Statement Line Items [Line Items]
Right-of-use assets, Term of Contract (Month)	6 years

Note 7 - Finance Income and Expense - Finance Income (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Statement Line Items [Line Items]
Net gain on investment portfolio held for trading (Note 14)	$ 0	$ 13,033	$ 8,477
Net loss on investment portfolio held for trading (Note 14)	(4,944)	0	0
Unrealized foreign exchange gain (loss)	(494)	2,365	166
Realized foreign exchange gain (loss)	$ (1,320)	$ (1,532)	$ (191)

Note 5 - Personnel Expenses, Including Share-based Remuneration (Details Textual) - shares	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Statement Line Items [Line Items]
Number of share options and other equity instruments granted in share-based payment arrangement (in shares)	2,030,825	401,818
Share-based payments arrangement, vesting schedule, in year one	25.00%
Share-based payments arrangement, vesting schedule, in year two	25.00%
Share-based payments arrangement, vesting schedule, in year three	25.00%
Share-based payments arrangement, vesting schedule, in year four	25.00%
Weighted average remaining contractual life of outstanding share options and other equity instruments (Year)	1 year 3 months 18 days	8 months 23 days

Note 14 - Financial Assets and Liabilities - Gain (Loss) on Trading Securities (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Statement Line Items [Line Items]
Realized net gain (loss)	$ 830	$ 10	$ 0
Change in unrealized net gain (loss)	0	113	0
Net gain (loss) on investment portfolio held for trading	$ (4,944)	$ 13,033	$ 8,477

Note 15 - Lease Liabilities and Other Loans - Changes in Liabilities Arising from Financing Activities (Details) $ in Thousands	12 Months Ended
	Dec. 31, 2021 USD ($)
Statement Line Items [Line Items]
Change in credit facility	$ 7,483

Note 18 - Related Parties (Details Textual)	12 Months Ended
Note 18 - Related Parties (Details Textual)	Dec. 31, 2021
Statement Line Items [Line Items]
Management fee, maximum percentage of net gain from investment activity	8.00%
Percent of advertising revenue under agreement	30.00%

Note 6 - Other Operating Expenses (Details Textual) $ in Millions	12 Months Ended
	Dec. 31, 2020 USD ($)
Statement Line Items [Line Items]
Professional fees expense, actions taken following a short seller report	$ 3.5

Note 12 - Associates, Joint Ventures, and Other Long-term Investments - Sensitivities Analysis (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Statement Line Items [Line Items]
Decrease	$ (5,115)	$ (3,093)
Increase	$ 5,103	$ 3,092

Note 4 - Segment and Revenue Information (Tables)

12 Months Ended

Dec. 31, 2021

Statement Line Items [Line Items]

Reconciliation of contribution by segment to net income (loss) [text block]

	Year ended December 31,
[US$ thousands]	2019			2020			2021
Contribution by segment		97,379			103,235			115,800
Other operating income		-			11,542			466
Personnel expenses including share-based remuneration ⁽¹⁾		(51,283	)		(59,977	)		(74,450	)
Credit loss expense related to divested joint venture		-			(10,476	)		-
Depreciation and amortization		(18,843	)		(20,234	)		(19,600	)
Impairment of non-financial assets		-			-			(5,624	)
Other operating expenses ⁽¹⁾		(27,791	)		(26,538	)		(22,802	)
Share of net income (loss) of equity-accounted investees		(3,818	)		2,005			(26,675	)
Impairment of equity-accounted investee		-			-			(118,178	)
Fair value gain on investments		37,900			24,000			116,561
Finance income		10,532			13,633			123
Finance expense		(655	)		(516	)		(6,912	)
Foreign exchange gain (loss)		(25	)		833			(1,814	)
Profit (loss) before income taxes from continuing operations		43,396			37,507			(43,106	)

Note 16 - Trade and Other Payables, and Other Current Liabilities (Tables)

12 Months Ended

Dec. 31, 2021

Statement Line Items [Line Items]

Disclosure of detailed information about trade and other payables [text block]

	As of December 31,
[US$ thousands]	2020		2021
Trade and other payables:
Trade payables due to third party suppliers		20,181		32,506
Trade and other payables due to related parties (Note 20)		2,268		1,505
Employee withholding tax		1,044		1,737
Value added tax		1,162		1,648
Payroll tax ⁽¹⁾		799		982
Total trade and other payables		25,454		38,378

Other current liabilities:
Accrued personnel expenses		11,985		11,793
Equity derivative liabilities (Note 14)		744		-
Unsettled trades (Note 14)		-		6,931
Other current liabilities		310		401
Total other current liabilities		13,040		19,125

Note 5 - Personnel Expenses, Including Share-based Remuneration - Research and Development Expenditure (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Statement Line Items [Line Items]
Less: Capitalized development expenditure excluded from personnel expenses (Note 11)	$ 4,862	$ 7,110	$ 4,056
Net expensed research and development expenditure	$ 39,193	$ 31,626	$ 30,087

Note 13 - Trade Receivables, Other Current Receivables, and Prepayments - Provision for Impairment of Trade Receivables (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Statement Line Items [Line Items]
Loss allowance related to trade receivables due from a former joint venture	$ (6,579)	$ 6,579

Note 3 - Corporate Information and Group Composition - Results of Discontinued Operations (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Statement Line Items [Line Items]
Profit (loss) before income tax	$ (1,053)	$ (11,576)	$ 20,105
Income tax benefit (expense)	237	1,950	(2,944)
Profit (loss) after income tax	$ (816)	$ (9,626)	$ 17,161

Note 11 - Goodwill and Intangible Assets (Details Textual)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Statement Line Items [Line Items]
Cash flows, annualized growth rate	16.00%
Cash generating unit, nominal growth rate	1.90%	2.50%
Risk-free rate, significant unobservable inputs, assets	1.60%	0.84%
Market risk premium rate, ignificant unobservable inputs, assets	4.84%	4.97%
Estimated beta for equity	0.88	0.91
Equity to total capital, percent	100.00%	100.00%
Sensitivity analysis, reasonably possible increase (decrease) in revenue	7.80%
Sensitivity analysis, reasonably possible increase (decrease) in operating expenditure	4.00%
Sensitivity analysis, reasonably possible increase (decrease) in WACC	6.30%

Note 12 - Associates, Joint Ventures, and Other Investments (Tables)

12 Months Ended

Dec. 31, 2021

Statement Line Items [Line Items]

Disclosure of carrying amounts of investments in associates and joint ventures [text block]

								Carrying amount of net investment as of December 31,
Investee	Nature of ownership interest	Ownership interest				Classification of investee	Basis of accounting	2020		2021
Nanobank	Ordinary shares		42.35	%		Associate held for sale ⁽¹⁾	FVLCTS ⁽²⁾		264,261		120,311
OPay	Ordinary and preferred shares		6.44	%	⁽³⁾	Financial asset held for sale ⁽¹⁾	FVTPL ^{(3, 4)}		45,220		84,600
Star X	Preferred shares		19.35	%		Associate held for sale ⁽¹⁾	FVTPL ⁽⁴⁾		55,000		83,468
nHorizon	Ordinary shares		29.09	%		Joint venture	Equity method		463		6
Fjord Bank	Ordinary shares		6.09	%		Non-current financial asset	FVTPL ⁽⁴⁾		-		897

	Year ended December 31,
[US$ thousands]	2020			2021
Carrying amount as of January 1		43,096			45,220
Share of net income (loss)		(876	)		(214	)
Change in fair value of preferred shares		3,000			29,415
Change in fair value of ordinary shares		-			29,094
Disposal		-			(18,915	)
Carrying amount as of December 31		45,220			84,600

	Year ended December 31,
[US$ thousands]	2019			2020			2021
Opera's share in %		29.09	%		29.09	%		29.09	%
Opera's share of net income (loss)		518			(535	)		(458	)
Opera's share in equity		886			391			(120	)
Equity method adjustments		77			72			126
Carrying amount as of December 31		963			463			6
Reconciliation of carrying amount:
Carrying amount as of January 1		443			963			463
Foreign exchange adjustments		3			35			1
Share of net income (loss)		518			(535	)		(458	)
Carrying amount as of December 31		963			463			6

Disclosure of sensitivity analysis for equity [text block]

		As of December 31, 2020						As of December 31, 2021
[US$ thousands]	Key unobservable input	Decrease			Increase			Decrease			Increase
Discount for lack of marketability (5 percentage points movement)	PWERM, OPM and CV ⁽¹⁾		2,811			(2,811	)		4,700			(4,700	)
Weighted average cost of capital (2 percentage points movement)	PWERM, OPM and CV ⁽¹⁾		1,087			(1,009	)		1,978			(1,885	)
Equity value of the company (10% movement)	OPM and CV ⁽¹⁾		(3,093	)		3,092			(5,115	)		5,103

Note 12 - Associates, Joint Ventures, and Other Long-term Investments - Carrying Amounts (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Statement Line Items [Line Items]
Ownership interest	6.09%	29.09%	29.09%
Carrying amount as of January 1	$ 463	$ 963	$ 443
Share of net income (loss)	(458)	(535)	518
Change in fair value of preferred shares	29,415	3,000
Change in fair value of ordinary shares	29,094	0
Disposal	(18,915)	0
Carrying amount as of December 31	6	463	963
Opera's share in equity	(120)	391	886
Equity method adjustments	126	72	77
Foreign exchange adjustments	$ 1	$ 35	$ 3

Note 4 - Segment and Revenue Information - Reconciliation (Details) - USD ($)
$ in Thousands

12 Months Ended

Dec. 31, 2021

Dec. 31, 2020

Dec. 31, 2019

Statement Line Items [Line Items]

Contribution by segment

$ 115,800

$ 103,235

$ 97,379

Personnel expenses including share-based remuneration (1)

^[1]

(74,450)

(59,977)

(51,283)

Credit loss expense related to divested joint venture

(10,476)

Other operating expenses (1)

^[1]

(22,802)

(26,538)

(27,791)

Impairment of equity-accounted investee

(118,178)

Fair value gain on investments

116,561

24,000

37,900

Profit (loss) before income taxes from continuing operations

$ (43,106)

$ 37,507

$ 43,396

[1]	Certain personnel and other operating expenses are included as part of "other cost of revenue" in the measure of segment profit. Accordingly, the amounts for personnel and other operating expenses in this reconciliation are not consistent with the equivalent amounts in the Statement of Operations.

Note 3 - Corporate Information and Group Information - Assets and Liabilities Recognised as a Result of Acquisition (Details) $ in Thousands	Jan. 11, 2021 USD ($)
Statement Line Items [Line Items]
Right-of-use assets (property)	$ 234
Trade receivables	131
Prepayments	8
Lease liabilities	234
Income tax payable	63
Other current liabilities	$ 67

Note 14 - Financial Assets and Liabilities (Tables)

12 Months Ended

Dec. 31, 2021

Statement Line Items [Line Items]

Disclosure of gain (loss) on trading securities [text block]

	Year ended December 31,
[US$ thousands]	2019			2020		2021
Listed equity securities:
Realized net gain (loss)		6,278			12,910		(11,201	)
Change in unrealized net gain (loss)		2,564			-		(11,696	)
Listed equity securities sold short:
Realized net gain (loss)		(365	)		-		17,123
Change in unrealized net gain (loss)		-			-		-
Equity derivatives:
Realized net gain (loss)		-			10		830
Change in unrealized net gain (loss)		-			113		-
Net gain (loss) on investment portfolio held for trading		8,477			13,033		(4,944	)

Note 13 - Trade Receivables, Other Current Receivables, and Prepayments (Tables)

12 Months Ended

Dec. 31, 2021

Statement Line Items [Line Items]

Disclosure of trade receivables, prepayments and other receivables [text block]

	As of December 31,
[US$ thousands]	2020			2021
Trade receivables due from third-party customers		34,927			44,510
Trade receivables due from associates and joint ventures (Note 20)		893			734
Trade receivables due from other related parties (Note 20)		632			1,417
Total gross trade receivables		36,452			46,661
Allowance for expected credit losses		(7,643	)		(2,796	)
Trade receivables net of loss allowance		28,809			43,864

	As of December 31,
[US$ thousands]	2020		2021
Other current receivables:
Value added tax		1,218		1,525
Receivable due from OPay		5,000		-
Unsettled trades (Note 14)		856		15,462
Other		4,600		1,551
Total other current receivables		11,674		18,538

Prepayments:
Prepaid equipment		-		1,073
Prepaid corporate income taxes		2,448		4,485
Other prepaid expenses		6,613		3,635
Total prepayments		9,061		9,192

Disclosure of aging of trade receivables [text block]

				Past due
[US$ thousands] As of December 31, 2020	Current (not past due)			<30 days			30-60 days			61-90 days			>91 days			Total
Weighted-average expected credit loss rate		0.4	%		2.8	%		1.2	%		16.2	%		82.4	%		21.0	%
Gross carrying amount		25,403			1,466			372			140			9,074			36,452
Loss allowance as of December 31, 2020		98			41			5			23			7,477			7,643

				Past due
[US$ thousands] As of December 31, 2021	Current (not past due)			<30 days			30-60 days			61-90 days			>91 days			Total
Weighted-average expected credit loss rate		0.4	%		1.8	%		2.5	%		3.2	%		50.3	%		6.0	%
Gross carrying amount		35,717			3,666			1,483			758			5,036			46,661
Loss allowance as of December 31, 2021		135			67			37			24			2,533			2,796

Provision for impairment of trade receivables [text block]

	As of December 31,
[US$ thousands]	2020			2021
Loss allowance as of period start		1,446			7,643
Loss allowance related to trade receivables due from a former joint venture		6,579			(6,579	)
Other changes in the period		(382	)		1,732
Loss allowance as of period end		7,643			2,796

Note 6 - Other Operating Expenses (Tables)

12 Months Ended

Dec. 31, 2021

Statement Line Items [Line Items]

Disclosure of other expenses by nature [text block]

	Year ended December 31,
[US$ thousands]	2019		2020		2021
Hosting		7,344		8,056		7,647
Audit, legal and other advisory services ⁽¹⁾		6,742		10,863		6,579
Software license fees		2,397		1,882		1,782
Rent and other office expenses		4,175		3,318		3,152
Travel		3,903		1,304		542
Other		3,686		2,774		3,101
Total other operating expenses		28,248		28,197		22,802

Note 4 - Segment and Revenue Information - Contribution by Segment (Details) - USD ($)
$ in Thousands

12 Months Ended

Dec. 31, 2021

Dec. 31, 2020

Dec. 31, 2019

Statement Line Items [Line Items]

Technology and platform fees

$ (573)

$ 0

Content cost

Other cost of revenue

(3,785)

(11,690)

Marketing and distribution expenses

(120,944)

(47,860)

(64,883)

Credit loss expense

^[1]

(557)

(1,849)

(577)

Total direct expenses

(135,191)

(61,821)

(79,699)

Contribution by segment

$ 115,800

$ 103,235

$ 97,379

[1]

For the Browser and News segment, Credit loss expense in the segment reporting is consistent with Other credit loss expense in the Statement of Operations, while for the Fintech segment, Credit loss expense is consistent with Other changes in fair value of loans to customers in the Statement of Operations.

Note 18 - Related Parties - Outstanding Balances and Transactions (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Statement Line Items [Line Items]
Other transactions	$ 0	$ 264,936	$ 0

Note 3 - Corporate Information and Group Composition (Details Textual) - USD ($) $ in Millions	Mar. 31, 2022	Jan. 20, 2022	Dec. 31, 2021	Jan. 17, 2021	Jan. 11, 2021	Aug. 19, 2020	Jan. 17, 2020	Dec. 31, 2019
Statement Line Items [Line Items]
Maximum capital capacity, invest in publicly traded securities			$ 70.0
Borrowing facilities, maximum borrowing capacity			$ 80.0
Share repurchase program, maximum authorized amount		$ 50.0					$ 50.0
Number of shares repurchased (in shares)	569,352		9,854,594	5,976,455				1,500,000
Consideration transferred, acquisition-date fair value, net of cash acquired					$ 9.0
Discontinued operations, cash and cash equivalents						$ 39.3

Note 8 - Income Tax - Reconciliation of Tax (Expense) Benefit (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Statement Line Items [Line Items]
Profit (loss) from continuing operations before income tax expense	$ (43,106)	$ 37,507	$ 43,396
Profit (loss) before income tax	(1,053)	(11,576)	20,105
Basis for calculation of the tax (expense) benefit	(44,159)	177,299	63,500
Effect of different tax rates applied by subsidiaries	(44,054)	11,543	(2,118)
Tax effect of translation differences exempted for tax	358	99	1,155
Tax effect of financial items exempted from tax	35,961	20,143	1,917
Tax effects of losses in equity-accounted investees which are non-deductible	(35)	(2,200)	383
Withholding taxes paid	(324)	(271)	(232)
Net other permanent differences (not) tax deductible	(2,008)	9,713	4,269
Change in income tax losses carried forward	(227)	246	27
Currency effect on income tax (expense) benefit and adjustments recognized in the period for current tax of prior periods	852	670	3,162
Change in withholding taxes and restricted interest deduction carried forward	147	952	(314)
Income tax (expense) benefit for the year	$ 194	$ 1,876	$ (5,602)

Note 5 - Personnel Expenses, Including Share-based Remuneration - RSUs and Option Activities (Details) - shares	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Statement Line Items [Line Items]
Outstanding at period start, total (in shares)	2,066,740	3,133,940
Granted during the year, total (in shares)	2,030,825	401,818
Forfeited during the year, total (in shares)	(244,700)	(346,200)
Exercised during the year, total (in shares)	(1,086,340)	(1,122,818)
Expired during the year, total (in shares)	0	0
Outstanding at period end, total (in shares)	2,766,525	2,066,740

Note 13 - Trade Receivables, Other Current Receivables, and Prepayments - Trade Receivables, Prepayments and Other Receivables (Details) - USD ($) $ in Thousands	Dec. 31, 2021	Dec. 31, 2020
Statement Line Items [Line Items]
Total gross trade receivables	$ 5,036	$ 9,074
Allowance for expected credit losses	(2,533)	(7,477)
Unsettled trades (Note 14)	15,462	856
Other	1,551	4,600
Prepaid equipment	1,073	0
Prepaid corporate income taxes	4,485	2,448
Other prepaid expenses	$ 3,635	$ 6,613

Note 6 - Other Operating Expenses - Other Expenses (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Statement Line Items [Line Items]
Hosting	$ 7,647	$ 8,056	$ 7,344
Software license fees	$ 1,782	$ 1,882	$ 2,397

Note 12 - Associates, Joint Ventures, and Other Investments (Details Textual) $ in Thousands		1 Months Ended	12 Months Ended				24 Months Ended
	Mar. 22, 2022 USD ($)	Jan. 31, 2021 shares	Dec. 31, 2021 USD ($) shares	Dec. 31, 2020 USD ($)	Dec. 31, 2019 USD ($)	Dec. 31, 2018 USD ($)	Dec. 31, 2019 USD ($)	Apr. 21, 2022 USD ($)
Statement Line Items [Line Items]
Gain (loss) on change in fair value of subsidiary				$ 151,400
Current assets or disposal groups classified as held for sale	$ 120,300		$ 288,379	0
Disposal group held for sale, consideration to be received	$ 127,100		$ 127,100					$ 83,500
Disposal group held for sale, consideration to be received, number of quarterly installments	8		8
Disposal group held for sale, consideration to be received, term (Year)	2 years		2 years
Disposal group held for sale, discount rate	5.00%		5.00%
Effect of one percent change in discount rate			$ 1,300
Shares in associate held (in shares) \| shares			69,962,470
Shares in associate sold (in shares) \| shares			10,302,955
Shares in associate sold, value			$ 50,000
Gains (losses) recognised in profit or loss including exchange differences, fair value measurement, associates equity			116,561	$ 24,000	$ 37,900
Net carrying amount of investment in associate			$ (4,000)
Preferred shares, DLOM			40.00%
Shares in associate purchased, value						$ 30,000	$ 6,500
Shares in associate purchased (in shares) \| shares		3,252,300
Investments in associates accounted for using equity method, ownership percentage		9.90%	6.09%

Note 8 - Income Tax (Tables)

12 Months Ended

Dec. 31, 2021

Statement Line Items [Line Items]

Major components of tax expense (income) [text block]

	Year ended December 31,
[US$ thousands]	2019			2020			2021
Current income taxes		(5,112	)		1,983			(4,109	)
Currency effect on income tax (expense) benefit and adjustments recognized in the period for current tax of prior periods ⁽¹⁾		(322	)		(1,272	)		852
Deferred taxes		(168	)		1,164			3,452
Income tax benefit (expense)		(5,602	)		1,876			194
Income tax expense is attributable to:
Profit from continuing operations		(2,658	)		(75	)		(43	)
Profit from discontinued operation		(2,944	)		1,950			237

Reconciliation of accounting profit multiplied by applicable tax rates [text block]

	Year ended December 31,
[US$ thousands]	2019			2020			2021
Profit (loss) from continuing operations before income tax expense		43,396			37,507			(43,106	)
Profit (loss) from discontinued operation before income tax expense		20,105			139,792			(1,053	)
Basis for calculation of the tax (expense) benefit		63,500			177,299			(44,159	)
Tax (expense) benefit at nominal tax rate in Norway		(13,970	)		(39,006	)		9,715
Effect of different tax rates applied by subsidiaries		(2,118	)		11,543			(44,054	)
Permanent differences:
Tax effect of translation differences exempted for tax		1,155			99			358
Tax effect of financial items exempted from tax		1,917			20,143			35,961
Tax effects of losses in equity-accounted investees which are non-deductible		383			(2,200	)		(35	)
Withholding taxes paid		(232	)		(271	)		(324	)
Net other permanent differences (not) tax deductible		4,269			9,713			(2,008	)
Other effects:
Change in income tax losses carried forward		27			246			(227	)
Currency effect on income tax (expense) benefit and adjustments recognized in the period for current tax of prior periods		3,162			670			852
Change in withholding taxes and restricted interest deduction carried forward		(314	)		952			147
Change in tax rate		119			(14	)		(190	)
Income tax (expense) benefit for the year		(5,602	)		1,876			194
Effective tax rate		8.8	%		(1.1	)%		0.4	%

Disclosure of changes in deferred taxes [text block]

	Year ended December 31,
[US$ thousands]	2020		2021
Net deferred tax liability as of January 1		4,322		7,362
Addition from business combination (Note 3)		-		48
Expense (benefit) in the Statement of Operations		3,040		(3,452	)
Expense (benefit) in the Statement of Comprehensive Income		-		251
Net deferred tax liability as of December 31		7,362		4,209